TRISALUS LF SC CM A (TLSI)
Health Care · Medical Devices (Interventional Oncology) · NASDAQ
TriSalus combines a proprietary pressure-enabled drug delivery (PEDD) platform with immunotherapy to overcome physical and biological barriers in treating solid tumors.
What TRISALUS LF SC CM A does
TriSalus Life Sciences is an oncology-focused medical technology company that develops proprietary delivery platforms to improve the efficacy of therapeutics for solid tumors. Its core Pressure-Enabled Drug Delivery (PEDD) technology, which includes the FDA-cleared TriNav Infusion System, modulates pressure and flow within blood vessels to overcome barriers like high intratumoral pressure. The company is also developing nelitolimod, an investigational class C TLR9 agonist immunotherapy, intended to reprogram the tumor microenvironment.
Recent developments
The company maintained its 2026 full-year revenue guidance of $54 million to $57 million. On June 17, 2026, CMS established a permanent HCPCS G-code for procedures using pressure-generating catheters in outpatient-based labs, effective July 1, 2026.
From TRISALUS LF SC CM A's filing of 2026-08-06.
Themes: interventional oncology, drug delivery technology, immuno-oncology, solid tumor treatment, liver cancer treatment, pancreatic cancer treatment, medical device reimbursement
Fundamentals
- Price$4.13 as of 2026-10-08 close
- Market cap$254M as of 2026-08-04 (share count; price 2026-10-08)
- 1-year return-14.8% 2025-10-08 close $4.85 → 2026-10-08 close $4.13
- P/En/a negative earnings
- Net margin-86.9% FY2025, SEC XBRL
- Gross margin+84.6% FY2025, SEC XBRL
- Debt / equity2.58 as of 2026-09-02
- Revenue growth (YoY)+39.6% as of 2026-09-02
- Revenue CAGR (3y)+53.9% SEC XBRL
- Beta0.57 as of 2026-09-02
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How TLSI compares in its sector
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-02
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-02
- gross margintop 25% 189 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRtop 25% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How TRISALUS LF SC CM A looks technically
TRISALUS LF SC CM A (TLSI) is trading 12.2% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed above its 200-day average about 12 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 35, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day low, its first since 2026-07-15, breaking below its recent trading range. It is 48.1% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 12.2% below its 200-day average, the long-term trend line — a long-term downtrend | -12.2% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $4.88 | $4.88 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $4.71 | $4.71 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 4.47. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible downward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 12 trading days ago — a "golden cross", a bullish long-term signal | 12 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 11, below the 25 that marks a real trend) | 10.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 35, neither overbought (above 70) nor oversold (below 30) | 35.4 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($4.02 to $5.83) — its "stochastic" reading is 6 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 6.1 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 11 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $7.95 | $7.95 |
|---|---|---|
| From the 52-week high | it is 48.1% below its 52-week high (its highest price of the past year) | -48.0% |
| Above the 52-week low | it is 87.7% above its 52-week low (its lowest price of the past year) | +87.7% |
| Below the 52-week high | it is 48.1% below its highest point of the past year | 48.0% |
| Since a 20-day breakout | it just made a new 20-day low, its first since 2026-07-15, breaking below its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day low, its first since 2026-07-15, breaking below its recent trading range | 1 session |
| All-time high | its highest closing price on record is $16.24 (set on 2023-08-11) | $16.24 |
| Given back of the 52-week move | over the past year its closes ranged ($2.52 to $7.50), and it has recovered roughly a third of its fall from last year’s high — 32% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $5.60 to $5.76. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 32.3% |
| From the all-time high | it is 74.6% below its all-time high | -74.6% |
| Nearest price level | it is trading 0.7% below a resistance level at $4.16 — a price it turned at twice since 2025-09-29, most recently on 2025-10-13. Since 2024-10-08 it has 3 such levels below the current price and 9 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.7% |
| All-time low | its lowest closing price on record is $2.20 (set on 2026-05-13) | $2.20 |
| Above the all-time low | it is 87.7% above its all-time low | +87.7% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 57th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.329 between its high and its low — about 8.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.329 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $3.94 and $5.21 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $3.94 – $4.57 – $5.21 |
| Typical daily range (% of price) | its price moves about 8.0% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 8.0% |
| Stretch from the 200-day average | it is trading 1.8 daily ranges below its 200-day average price (12.2% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.8 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.76× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|---|---|
| Since a hammer | today, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | today |
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
Price gaps
3
| Gap at the open | it opened on 2026-10-08 2.8% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | -2.8% |
|---|---|---|
| Open gap | it gapped 2.8% below the previous close today and has not traded back through the level it left behind at 4.25 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -2.8% |
| Gap filled | a 17.2% gap up opened on 2026-09-23 has been "filled" 11 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 11 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 3 sessions in a row, a -5.71% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 3 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 13.7 percentage points (the stock lost 12.7% while the market gained 1.0%) | -13.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 8.4 percentage points (the stock gained 12.2% while the market gained 3.8%) | +8.4% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 16.2 percentage points (the stock gained 1.2% while the market gained 17.5%) | -16.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 29.8 percentage points (the stock lost 14.8% while the market gained 15.0%) | -29.8% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 14% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 6.6% of the share price. | -13.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 1% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $4.17 — a volume-weighted average of daily closes over 188 sessions, not a true tick-by-tick VWAP. | -1.1% |
|---|---|---|
| Vs the average paid since it last reported | the price is 16% below the average price paid since it last reported on 2026-08-06 (its 10-Q), so the typical buyer over that stretch is under water. That average is $4.91 — a volume-weighted average of daily closes over 45 sessions, not a true tick-by-tick VWAP. | -15.9% |
Price levels it has turned at before
TLSI last closed at $4.13 on 2026-10-08. Since 2024-10-08 it has turned at 3 prices below its last close and 9 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $4.16 | Resistance | 0.7% above the last close | turned there twice · 2025-09-29 to 2025-10-13 |
| $4.01 | Support | 2.9% below the last close | turned there twice · 2026-07-24 to 2026-10-01 |
| $4.43 | Resistance | 7.4% above the last close | turned there six times · 2025-09-12 to 2026-09-16 |
| $3.78 | Support | 8.4% below the last close | turned there twice · 2024-11-04 to 2025-11-14 |
| $4.65 | Resistance | 12.7% above the last close | turned there four times · 2024-11-14 to 2026-08-28 |
| $3.60 | Support | 12.7% below the last close | turned there twice · 2024-12-19 to 2026-03-30 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $4.47.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $4.45 and $4.47 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close below $4.02.
This reading has stood for 1 trading day, since 2026-10-08.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Pulled back from the 12-month high · Broke down to a new 20-day low · trendless / choppy (low ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.20 mean, 1=Strong Buy…5=Strong Sell) — 5 analysts
- Mean price target$10.40 range $7.00 – $14.00; median $11.00
Analyst estimates, as of 2026-10-06. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["Dependence on continued reimbursement coverage and favorable coding from CMS for the TriNav device family.","Significant operating losses and reliance on future financing or partnerships to fund commercial expansion and nelitolimod development.","High competition in the medical device market and challenges in recruiting/retaining specialized commercial sales talent."]
What changed in the latest 10-Q
AI-assisted comparison of TLSI's 10-Q filed 2026-05-12 against the prior one filed 2025-11-13.
Management's Discussion & Analysis (MD&A)
- Added:
- Added full company name 'TriSalus Life Sciences, Inc.' with parenthetical clarification of pronouns used in section
- Added reference to 'TriSalus' as alternative name for the Company
- Added reference to audited financial statements 'as of and for the year ended December 31, 2025'
- Added SEC filing date 'March 5, 2026' for the Annual Report on Form 10-K
- Removed:
- Removed reference to year ended December 31, 2024
- Removed SEC filing date 'April 15, 2025' for prior year Annual Report
- Removed phrase 'For a complete discussion of forward-looking statements, see the section above entitled'
- Removed quotation mark closure around 'Cautionary Note Regarding Forward Looking Statements'
- Reworded:
- Changed 'should be read in conjunction with' to 'should be read together with'
- Changed 'TriSalus' condensed consolidated financial statements' to 'TriSalus' condensed consolidated financial statements' (added possessive clarification with company name)
- Changed 'Information included in this Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements' to 'Some of the information contained in this discussion and analysis includes forward-looking statements'
- Changed reference from 'section above entitled' to 'section titled'
- Notes:
- Both document excerpts are truncated at the same point ('section captioned "'), limiting full comparison of subsequent content
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 3 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 30 days · read to 2026-10-040 buys · 3 sells ($4113) — 3 selling insiders
- Last 90 days · read to 2026-10-040 buys · 3 sells ($4113) — 3 selling insiders
- Last 180 days · read to 2026-10-046 buys ($2M) · 4 sells ($5563) — 5 buying, 3 selling insiders
Cluster buying: 5 different insiders reported open-market purchases (SEC code P) of TLSI within a 30-day window between 2026-05-15 and 2026-05-15. Disclosed Form 4 activity, not a prediction of performance or a buy signal.
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-10-05. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about TLSI's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
3 institutional 13F filers reported holding TLSI as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 3
- Reported shares held 3,272,739
- Reported value $14,890,963
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 0 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about TLSI's institutional holders → See what each manager we track holds →
Short interest (FINRA)
TLSI had 3,345,269 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
TLSI had 5.43% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 28.81 days to cover at the same settlement.
- Reported short interest (shares) 3,345,269
- Short interest (% of shares outstanding) 5.43%
- Prior settlement (shares) 3,692,615
- Reported change -9.41%
- Days to cover (reported) 28.81
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Boston Scientific (BSX)
- Medtronic (MDT)
- Becton, Dickinson and Company (BDX)
- Cook Medical
- Terumo Corporation
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare TLSI vs…
TRISALUS LF SC CM A is found in…
Frequently asked questions
What does TRISALUS LF SC CM A (TLSI) do?
TriSalus Life Sciences is an oncology-focused medical technology company that develops proprietary delivery platforms to improve the efficacy of therapeutics for solid tumors. Its core Pressure-Enabled Drug Delivery (PEDD) technology, which includes the FDA-cleared TriNav Infusion System, modulates pressure and flow within blood vessels to overcome barriers like high intratumoral pressure.
What sector is TRISALUS LF SC CM A (TLSI) in?
TRISALUS LF SC CM A (TLSI) is classified in the Health Care sector. Its industry is Medical Devices (Interventional Oncology). It trades on NASDAQ.
Who are TRISALUS LF SC CM A's (TLSI) competitors?
Notable peers of TRISALUS LF SC CM A (TLSI) include Boston Scientific, Medtronic, Becton, Dickinson and Company, Cook Medical and Terumo Corporation. This peer set is informational only — not financial advice.
Is TRISALUS LF SC CM A (TLSI) overbought or oversold right now?
TRISALUS LF SC CM A (TLSI) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 35, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on TLSI come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.